Skip to content

Sedation and Duration of Spinal Anesthesia For Cesarean Section with IV Midazolam or Dexmedetomidine

Comparison of the effect of Intravenous Midazolam with Dexmedetomidine Infusion on Sedation and Duration of Spinal Anesthesia with Bupivacaine For Cesarean Section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016111410765N12
Enrollment
70
Registered
2016-12-07
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse effect of drug. Complication of surgical and medical care, unspecified

Interventions

Intervention 1: Intervention Group: The patients will be received 1 µg/kg of dexmedetomidine in 20 cc normal saline intravenously by over 10 min. Intervention 2: Patients will be received midazolam 0.
Treatment - Drugs
Intervention Group: The patients will be received 1 µg/kg of dexmedetomidine in 20 cc normal saline intravenously by over 10 min.
Patients will be received midazolam 0.03 mg/kg intravenously.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Parturients candidate for elective cesarean section; ASA Class I & II;patients will give written informed consent Exclusion criteria: Parturients with ASA Class III or higher; spinal anesthesia contraindications; Diabetics; preterm labor;hypertensive parturients; preeclampsia and eclampsia; hypotension; bradycardia; drug allergy; alcohol abuse; patients with cardiovascular; respiratory, renal; hepatic diesease ?

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sedation. Timepoint: During surgery and ricovery. Method of measurement: Ramsay sedation score (0-6).

Secondary

MeasureTime frame
Blood pressure. Timepoint: During surgery and recovery. Method of measurement: Non invasive.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSousan Rasouli

Reaserch center, Tabriz University of Medical Scienses

Rasooli_s@yahoo.com+98 415539161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026